About Us

At CD BioSciences, we are dedicated to transforming the landscape of human herpesvirus (HHV) research. As a specialized service and solution provider, we partner with pharmaceutical companies, academic institutions, and biotechnology enterprises worldwide, supporting their discovery and preclinical development programs with deep scientific expertise and innovative technical platforms.

Our Mission & Vision

Mission

To accelerate scientific discovery and therapeutic innovation in the field of human herpesvirus by delivering reliable products, specialized research services, and integrated preclinical solutions tailored to the unique needs of each client.

Vision

To be recognized globally as the leading partner in HHV-focused research services and technologies, empowering breakthroughs that improve global health and deepen scientific understanding of the human herpesvirus family.

We firmly believe that specialized focus drives exceptional results. By concentrating exclusively on the HHV field—including all nine recognized human herpesviruses—we bring unmatched depth, precision, and innovation to every project.

Our History

Founded with the vision of bridging critical research gaps in HHV biology and drug development, CD BioSciences has grown into a trusted partner for organizations pursuing therapies, diagnostics, and scientific knowledge related to herpesviruses.

Our journey began when our team recognized that researchers and biotech companies often lacked comprehensive support specific to HHV. While many CROs offered general virology services, few provided focused expertise in this complex virus family, whose latent infection, reactivation, and pathogenesis mechanisms present unique scientific challenges.

Since our inception, we have continuously expanded our portfolio. Today, we offer a full spectrum of HHV-related research reagents, assay systems, in vitro models, and customized service packages, covering research and preclinical stages from early discovery to preclinical candidate evaluation. Our dedicated scientific teams stay at the forefront of herpesvirus research, ensuring our clients access not only reliable technical execution but also cutting-edge scientific insight.

Our Facilities

CD BioSciences' advanced facilities are purpose-built to meet the complex demands of HHV research:

Virus Culture & Assay Platforms: Equipped with high-throughput viral replication, infectivity, and neutralization assay systems designed specifically for HHV strains.
Molecular & Cell Biology Laboratories: Featuring real-time PCR, next-generation sequencing, flow cytometry, and advanced imaging systems to characterize viral behavior and host interactions.
Protein and Antigen Production Suites: For large-scale production and purification of viral proteins, antigens, and monoclonal antibodies used in assays and therapeutic research.
Bioinformatics & Data Analysis Unit: Providing comprehensive analysis of viral genomes, transcriptomes, and proteomes to support discovery and biomarker studies.

All facilities operate under rigorous quality management systems. Our teams regularly update protocols in line with international best practices, ensuring data reproducibility, scientific validity, and compliance with regulatory standards relevant to preclinical research.

Expert Team

At the heart of CD BioSciences is a team of dedicated scientists and technical specialists who bring decades of experience in virology, molecular biology, immunology, and translational research.

What sets our team apart:

Deep HHV Expertise: Many of our scientists have worked extensively on projects related to all nine human herpesviruses, from basic research to applied solutions.
Interdisciplinary Collaboration: We foster an environment where experts from diverse fields — including bioinformatics, cell biology, and assay development — collaborate to deliver comprehensive solutions.
Client-Focused Approach: Our scientists partner closely with clients to design customized research strategies and solve complex scientific challenges.

By combining technical expertise with a collaborative mindset, our team helps transform scientific questions into actionable research outcomes.

Commitment to Excellence

Beyond infrastructure, what truly sets CD BioSciences apart is our team’s collective expertise. Many of our scientists hold advanced degrees and bring years of dedicated herpesvirus research experience. This specialized knowledge allows us to advise clients on experimental design, troubleshoot complex projects, and propose innovative approaches to scientific challenges.

We view every client relationship as a partnership. By listening to our clients’ goals, we tailor solutions that maximize scientific value, reduce risk, and shorten timelines. Our focus on open communication and transparent project management further strengthens this collaborative approach.

Looking Ahead

The burden of HHV-related diseases—including cancers, autoimmune conditions, and chronic infections—remains significant. At CD BioSciences, we are committed to being at the forefront of new discoveries, enabling our partners to translate promising research into transformative therapies and diagnostics.

Through our mission-driven approach, specialized facilities, and deeply experienced team, we continue to empower global efforts against human herpesviruses — and we look forward to partnering with you in this vital work.